BR0309375A - Tratamento de sìndrome metabólica - Google Patents

Tratamento de sìndrome metabólica

Info

Publication number
BR0309375A
BR0309375A BR0309375-1A BR0309375A BR0309375A BR 0309375 A BR0309375 A BR 0309375A BR 0309375 A BR0309375 A BR 0309375A BR 0309375 A BR0309375 A BR 0309375A
Authority
BR
Brazil
Prior art keywords
treatment
metabolic syndrome
metformin
analog
growth hormone
Prior art date
Application number
BR0309375-1A
Other languages
English (en)
Inventor
Bernhard Saller
Original Assignee
Pfizer Health Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0209642A external-priority patent/GB0209642D0/en
Priority claimed from GB0218912A external-priority patent/GB0218912D0/en
Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab
Publication of BR0309375A publication Critical patent/BR0309375A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Abstract

"TRATAMENTO DE SìNDROME METABóLICA". A presente invenção refere-se ao uso de um hormónio de crescimento ou um seu análogo com um agente de sensibilização de insulina (por exemplo, metformin) no tratamento de síndrome metabólica.
BR0309375-1A 2002-04-26 2003-04-24 Tratamento de sìndrome metabólica BR0309375A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0209642A GB0209642D0 (en) 2002-04-26 2002-04-26 Metabolic syndrome
GB0218912A GB0218912D0 (en) 2002-08-14 2002-08-14 Metabolic syndrome
PCT/EP2003/004357 WO2003090784A1 (en) 2002-04-26 2003-04-24 Treatment of metabolic syndrome

Publications (1)

Publication Number Publication Date
BR0309375A true BR0309375A (pt) 2005-03-29

Family

ID=29272006

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309375-1A BR0309375A (pt) 2002-04-26 2003-04-24 Tratamento de sìndrome metabólica

Country Status (11)

Country Link
EP (1) EP1499357A1 (pt)
JP (1) JP2005523915A (pt)
KR (1) KR20040101545A (pt)
CN (1) CN1646167A (pt)
AU (1) AU2003227683A1 (pt)
BR (1) BR0309375A (pt)
CA (1) CA2483005A1 (pt)
IL (1) IL164670A0 (pt)
MX (1) MXPA04010544A (pt)
PL (1) PL372900A1 (pt)
WO (1) WO2003090784A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2533799B8 (en) * 2010-02-08 2019-12-25 Shenzhen Evergreen Therapeutics Co., Ltd. Methods for the use of progestogen as a glucocorticoid sensitizer

Also Published As

Publication number Publication date
CN1646167A (zh) 2005-07-27
EP1499357A1 (en) 2005-01-26
CA2483005A1 (en) 2003-11-06
IL164670A0 (en) 2005-12-18
KR20040101545A (ko) 2004-12-02
MXPA04010544A (es) 2005-08-16
JP2005523915A (ja) 2005-08-11
AU2003227683A1 (en) 2003-11-10
PL372900A1 (en) 2005-08-08
WO2003090784A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
TR200001892T2 (tr) Monomer cinsi ensülin analogları ve bunların kullanımı.
SE0001899D0 (sv) New compounds
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR0306868A (pt) Composições incluindo bactérias oxidando amonìaco e métodos para usar as mesmas
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
RS52629B (en) LIXISENATIDE AS ADDITIONAL THERAPY INSULIN GLARGINE AND METFORMIN FOR TYPE 2 DIABETES TREATMENT
SE9201573D0 (sv) Use of igf-1
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
EE200200087A (et) Kompositsioon hepatotsellulaarse kartsinoomi raviks
MXPA03002160A (es) Metodo para el tratamiento de resistencia a insulina en obesidad y diabetes.
BR0317947A (pt) Inibidores de quinurenina 3-hidroxilase para o tratamento de diabetes
BR0309375A (pt) Tratamento de sìndrome metabólica
SE0103276D0 (sv) Anordning för administrering av salva till en hudyta
BRPI0506793A (pt) métodos de tratamento de obesidade ou diabetes com o uso de nt-4/5
ES2108122T3 (es) Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
AR008025A1 (es) Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina
DK1675611T3 (da) Terapeutiske anvendelser for C-peptid
BR0208109A (pt) Derivados de guanidina bicìclicos e usos terapêuticos destes
RS20050776A (en) A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment diabetes
BR0010499A (pt) Agentes endoparasiticidas
WO2006010127A3 (en) Therapeutic compound and treatments

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES.

B08J Incorrect entry in the gazette republished [chapter 8.10 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2051 DE 27/04/2010. TEXTO CORRETO: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.10 DA RPI 2068 DE 24/08/2010.